Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Abnorm Psychol. 2016 May 12;125(6):777–787. doi: 10.1037/abn0000164

Table 1.

Participant Characteristics

Characteristics Healthy Controls (N=30) Individuals with Schizophrenia (N=33)

Demographics Mean SD Mean SD p-value
Age (years) 35.9 8.2 36.7 9.25 0.72
Sex (% male) 46.7% 51.5% 0.70
Ethnicity
African-American 58.0% 56.7%
Caucasian 42.0% 43.3%
Personal Education (years) 15.2 2.7 12.8 2.3 <0.001
Parental Education (years) 14.4 2.6 14.4 3.50 0.97
Medication status
Atypical antipsychotics (%) NA 55%
Typical antipsychotics (%) NA 3%
Typical and atypical (%) NA 6%
Medicated (no antipsychotics) 15%
Not Medicated (%) NA 21%
Olanzapine Equivalent Dose NA 14.7 9.2
Clinical ratings
Brief Negative Symptom Scale
Total Score NA 24.5 13.2
Avolition/Anhedonia Subscale NA 16.0 8.8
Self-Report
Snaith Hamilton Pleasure Scale 50.7 5.9 43.5 10.5 0.001
Neurocognitive Measures
Wechsler Test of Adult Reading 101.2 14.3 98.3 12.0 0.39